Last updated: August 17, 2022
Sponsor: Leiden University Medical Center
Overall Status: Active - Recruiting
Phase
3
Condition
N/ATreatment
N/AClinical Study ID
NCT05507710
NL 68623.058.18
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Female patients 18 years of age and older
- Who underwent a mastectomy for breast cancer or prophylactic due to geneticpredisposition
- Patients scheduled for elective surgery for autologous breast reconstruction, uni- orbilateral, using DIEP or msTRAM flaps. In case of bilateral breast reconstruction theflaps should be bilateral anastomosed.
- Written informed consent
Exclusion
Exclusion Criteria:
- Allergy to ICG, iodine or shellfish
- Any medical condition that in the opinion of the investigators could potentiallyjeopardize the safety of the patient
- Impaired renal function defined as eGFR< 50 mL/min/1.73m2 (this can be seen in thestandard preoperative lab results)
Study Design
Total Participants: 280
Study Start date:
May 01, 2019
Estimated Completion Date:
October 01, 2025
Study Description
Connect with a study center
Leiden University Medical Center
Leiden, 2333ZA
NetherlandsActive - Recruiting
Erasmus Medical Center
Rotterdam, 3015GD
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.